Compounds > halothane
Page last updated: 2024-10-28

halothane and Hypoparathyroidism

halothane has been researched along with Hypoparathyroidism in 2 studies

Hypoparathyroidism: A condition caused by a deficiency of PARATHYROID HORMONE (or PTH). It is characterized by HYPOCALCEMIA and hyperphosphatemia. Hypocalcemia leads to TETANY. The acquired form is due to removal or injuries to the PARATHYROID GLANDS. The congenital form is due to mutations of genes, such as TBX1; (see DIGEORGE SYNDROME); CASR encoding CALCIUM-SENSING RECEPTOR; or PTH encoding parathyroid hormone.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Read, AE1
Reeve, TS1
Hales, IB1
White, B1
Thomas, ID1
Hunt, PS1

Reviews

1 review available for halothane and Hypoparathyroidism

ArticleYear
Immunological liver disease.
    Journal of the Royal College of Physicians of London, 1973, Volume: 8, Issue:1

    Topics: Acidosis, Renal Tubular; Autoimmune Diseases; Chemical and Drug Induced Liver Injury; Cholangiograph

1973

Other Studies

1 other study available for halothane and Hypoparathyroidism

ArticleYear
Thyroidectomy in the management of thyrotoxicosis in the adolescent.
    Surgery, 1969, Volume: 65, Issue:4

    Topics: Adolescent; Anesthesia, General; Carbimazole; Female; Follow-Up Studies; Goiter; Halothane; Horner S

1969